Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters

Language
Document Type
Year range
1.
Archives of Pediatric Infectious Diseases ; 11(1) (no pagination), 2023.
Article in English | EMBASE | ID: covidwho-2288216

ABSTRACT

Background: The large proportion of coronavirus disease 2019 (COVID-19) patients has been associated with a large number of neu-ropsychiatric manifestations. Despite the high prevalence of COVID-19, few studies have examined such manifestations, especially in children and adolescents. Objective(s): This study investigated neuropsychiatric manifestations in hospitalized children and adolescents admitted for COVID-19 infection in Iran. Method(s): This prospective observational study included admitted children and adolescents (4-18 years old) diagnosed with COVID-19 infection, pediatric neurologists, child and adolescent psychiatrists, and infectious disease specialists, and assessed 375 infected patients during August and December 2021. Result(s): Of the 375 patients, 176 (47%) were female, with a mean age of 9.0 +/- 3.39 years. Psychiatric and neurological manifestations were reported in 58 (15.5%) and 58 (15.5%) patients, respectively. The most prevalent psychiatric disorders were separation anxiety disorder (SAD) (5.1%), major depressive disorder (MDD) (3.5%), generalized anxiety disorder (GAD) (2.7%), insomnia (2.4%), and op-positional defiant disorder (ODD) (2.4%). Regarding neurological complications, seizures were the most prevalent (13.1%), followed by encephalitis (1.9%), transverse myelitis (0.3%), acute ischemic stroke (0.3%), and Guillain-Barre syndrome (0.3%). There was no significant relationship between the duration of COVID-19 infection (P = 0.54) and ICU admission (P = 0.44) with the emergence of psychiatric symptoms. Conclusion(s): The most prevalent neurologic and psychiatric complications among children and adolescents with COVID-19 infection were seizures and the symptoms of anxiety/mood disorders, respectively.Copyright © 2023, Author(s).

2.
Journal of Client-Centered Nursing Care ; 8(4):291-302, 2022.
Article in English | Scopus | ID: covidwho-2218091

ABSTRACT

Background: Mothers may experience a great deal of fear and anxiety during their child's hospitalization during a pandemic, which can affect their decision to proceed with the child's treatment. This study was conducted with the aim of determining the relationship between mental status and fear of COVID-19 in mothers of children with chronic diseases, hospitalized during the pandemic in 2021. Methods: This is a descriptive correlational study. The research sample was 196 mothers of children with chronic diseases hospitalized in hospitals affiliated with the Iran University of Medical Sciences in Tehran, Iran who were selected by convenience sampling. Data were collected using the Fear of COVID-19 Scale and the Hospital Depression and Anxiety Scale (HADS) and analyzed by SPSS software, version 22, using analysis of variance, independent two-sample t-test, Pearson correlation test, and regression analysis. The significance level was set at 0.05. Results: The Mean±SD of hospital anxiety, depression, and fear of COVID-19 were 9.6±3.2, 10.86±2.2, and 10.8±2.2, respectively. Most mothers suffered from borderline anxiety (63.3%) and depression (86.7%). There was a significant association between hospital anxiety (P<0.001) and depression (P<0.001) with fear of COVID-19. The mothers' hospital anxiety was significantly associated with the child's type of disease (P<0.001) and the frequency of hospitalizations (P=0.1). Besides, there was a direct relationship between hospital depression with the child's age (P=0.3) and length of hospitalization (P=0.002). Furthermore, their fear of COVID-19 had a significant relationship with the child's age (P=0.008), type of disease (P<0.000), and length and frequency of hospitalizations (P<0.000). Conclusion: Providing the possibility of receiving mental health counseling during the hospitalization of children seems necessary considering the conditions of mothers during the epidemic. © 2022 The authors.

3.
Archives of Pediatric Infectious Diseases ; 10, 2022.
Article in English | Scopus | ID: covidwho-1789631

ABSTRACT

Guillain-Barre syndrome (GBS) characterizes a monophasic ascending, symmetrical paralysis, with areflexia, progressing over days to weeks. Normally, as a post-infectious autoimmune procedure, it leads to destroying myelin. Scattered reports exist regarding the concurrent evidence of COVID-19 infection and adults with possible GBS. However, few former cases were reported in children. Here in, we report an 11 years-old boy with GBS concurrent with COVID-19 infection. © 2021, Author(s).

SELECTION OF CITATIONS
SEARCH DETAIL